Afaf Abed - Search Results

Year	Number of Results
2020	4
2021	1
2022	5
2023	2
2024	0

1

Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression.

Marsavela G, McEvoy AC, Pereira MR, Reid AL, Al-Ogaili Z, Warburton L, Khattak MA, Abed A, Meniawy TM, Millward M, Ziman MR, Calapre L, Gray ES. Marsavela G, et al. Among authors: abed a. Br J Cancer. 2022 Feb;126(3):401-408. doi: 10.1038/s41416-021-01507-6. Epub 2021 Aug 9. Br J Cancer. 2022. PMID: 34373567 Free PMC article.

2

Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer.

Acheampong E, Abed A, Morici M, Spencer I, Beasley AB, Bowyer S, Asante DB, Lomma C, Lin W, Millward M, Gray ES. Acheampong E, et al. Among authors: abed a. Transl Lung Cancer Res. 2022 Mar;11(3):440-451. doi: 10.21037/tlcr-21-819. Transl Lung Cancer Res. 2022. PMID: 35399573 Free PMC article.

3

Human leucocyte antigen genotype association with the development of immune-related adverse events in patients with non-small cell lung cancer treated with single agent immunotherapy.

Abed A, Law N, Calapre L, Lo J, Bhat V, Bowyer S, Millward M, Gray ES. Abed A, et al. Eur J Cancer. 2022 Sep;172:98-106. doi: 10.1016/j.ejca.2022.05.021. Epub 2022 Jun 24. Eur J Cancer. 2022. PMID: 35759816 Free article.

4

Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Acheampong E, Abed A, Morici M, Bowyer S, Amanuel B, Lin W, Millward M, Gray ES. Acheampong E, et al. Among authors: abed a. Cells. 2020 Oct 31;9(11):2393. doi: 10.3390/cells9112393. Cells. 2020. PMID: 33142852 Free PMC article.

5

A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab.

Shen Y, Li J, Qiang H, Lei Y, Chang Q, Zhong R, Stella GM, Gelsomino F, Kim YW, Abed A, Qian J, Chu T. Shen Y, et al. Among authors: abed a. Transl Lung Cancer Res. 2022 Aug;11(8):1619-1630. doi: 10.21037/tlcr-22-493. Transl Lung Cancer Res. 2022. PMID: 36090639 Free PMC article.

6

Powering single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients.

Acheampong E, Morici M, Abed A, Bowyer S, Asante DB, Lin W, Millward M, Gray ES, Beasley AB. Acheampong E, et al. Among authors: abed a. J Cancer Res Clin Oncol. 2023 May;149(5):1941-1950. doi: 10.1007/s00432-022-04202-y. Epub 2022 Jul 28. J Cancer Res Clin Oncol. 2023. PMID: 35896898 Free PMC article.

7

Association of Computed Tomography Measures of Muscle and Adipose Tissue and Progressive Changes throughout Treatment with Clinical Endpoints in Patients with Advanced Lung Cancer Treated with Immune Checkpoint Inhibitors.

Khan A, Welman CJ, Abed A, O'Hanlon S, Redfern A, Azim S, Lopez P, Singh F, Khattak A. Khan A, et al. Among authors: abed a. Cancers (Basel). 2023 Feb 22;15(5):1382. doi: 10.3390/cancers15051382. Cancers (Basel). 2023. PMID: 36900175 Free PMC article.

8

Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy.

Abed A, Calapre L, Lo J, Correia S, Bowyer S, Chopra A, Watson M, Khattak MA, Millward M, Gray ES. Abed A, et al. J Immunother Cancer. 2020 Nov;8(2):e001620. doi: 10.1136/jitc-2020-001620. J Immunother Cancer. 2020. PMID: 33229510 Free PMC article.

9

Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy.

Marsavela G, Lee J, Calapre L, Wong SQ, Pereira MR, McEvoy AC, Reid AL, Robinson C, Warburton L, Abed A, Khattak MA, Meniawy TM, Dawson SJ, Sandhu S, Carlino MS, Menzies AM, Scolyer RA, Long GV, Amanuel B, Millward M, Ziman MR, Rizos H, Gray ES. Marsavela G, et al. Among authors: abed a. Clin Cancer Res. 2020 Nov 15;26(22):5926-5933. doi: 10.1158/1078-0432.CCR-20-2251. Epub 2020 Oct 16. Clin Cancer Res. 2020. PMID: 33067256

10

Role of Serum Vascular Endothelial Growth Factor (VEGF) as a Potential Biomarker of Response to Immune Checkpoint Inhibitor Therapy in Advanced Melanoma: Results of a Pilot Study.

Khattak MA, Abed A, Reid AL, McEvoy AC, Millward M, Ziman M, Gray ES. Khattak MA, et al. Among authors: abed a. Front Oncol. 2020 Jun 30;10:1041. doi: 10.3389/fonc.2020.01041. eCollection 2020. Front Oncol. 2020. PMID: 32695680 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year